Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial
Study achieves primary endpoint of radiographic progression-free survival
Study achieves primary endpoint of radiographic progression-free survival
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
This win is on the back of a prestigious order from Reliance Life Sciences
The inspection concluded with no observation (FDA-483) issued.
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Construction is now underway with the facility scheduled to be operational by 2025
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
Subscribe To Our Newsletter & Stay Updated